High materiality8/10
Nurix Therapeutics price target raised to $32 from $30 at Truist
Why it may matterVerify against the original reporting
bullish_upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises Nurix Therapeutics price target to $32 from $30; current price $15.64; upside >100%.
- PT $32; price $15.64; upside >100%.
Key facts
- 01
Target: $32
- 02
Posted price: $15.64
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.